Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nicholas Spellmon
Allosterically Targeting EGFR Drug-Resistance Gatekeeper Mutations
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Related publications
EGFR Mutations and Resistance to Irreversible Pyrimidine-Based EGFR Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
Targeting Oncoprotein Stability Overcomes Drug Resistance Caused by FLT3 Kinase Domain Mutations
PLoS ONE
Multidisciplinary
Akt Kinase-Interacting Protein1, a Novel Therapeutic Target for Lung Cancer With EGFR-activating and Gatekeeper Mutations
Oncogene
Cancer Research
Genetics
Molecular Biology
Targeting Autophagy for Overcoming Resistance to Anti-Egfr Treatments
Cancers
Cancer Research
Oncology
Overcoming Drug Resistance by Co-Targeting
Targeting Efflux Pumps to Overcome Antifungal Drug Resistance
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
EGFR T790M and C797S Mutations as Mechanisms of Acquired Resistance to Dacomitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients
Oncology Reports
Medicine
Cancer Research
Oncology